Preeti Shah

1.1k total citations
30 papers, 827 citations indexed

About

Preeti Shah is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Preeti Shah has authored 30 papers receiving a total of 827 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Oncology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Preeti Shah's work include Cancer Cells and Metastasis (8 papers), Estrogen and related hormone effects (5 papers) and Histone Deacetylase Inhibitors Research (5 papers). Preeti Shah is often cited by papers focused on Cancer Cells and Metastasis (8 papers), Estrogen and related hormone effects (5 papers) and Histone Deacetylase Inhibitors Research (5 papers). Preeti Shah collaborates with scholars based in United States, India and United Kingdom. Preeti Shah's co-authors include Gauri Sabnis, Armina A. Kazi, Angela Brodie, Olga Goloubeva, Michelle A. Rudek, David M. Loeb, Manish Banker, Ola Awad, Sarita Gupta and Naheed Gul and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Preeti Shah

30 papers receiving 819 citations

Peers

Preeti Shah

ONCOL

PRM

GENET

Andy Göbel Germany

Arezoo Astanehe Canada

Meaghan A. Delaney United States

Ruth F. Dumpit United States

Yohei Sekino Japan

Els Hermans Belgium

CL Arteaga United States

Jian‐Yong Ding China

Tao Zhao China

Ira Kogan-Sakin Israel

Andy Göbel Germany

Preeti Shah

471 ×0.9

298 ×0.9

ONCOL

323 ×1.4

156 ×0.7

PRM

57 ×1.1

GENET

Citations per year, relative to Preeti Shah Preeti Shah (= 1×) peers Andy Göbel

Countries citing papers authored by Preeti Shah

Since Specialization

Citations

This map shows the geographic impact of Preeti Shah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Preeti Shah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Preeti Shah more than expected).

Fields of papers citing papers by Preeti Shah

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Preeti Shah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Preeti Shah. The network helps show where Preeti Shah may publish in the future.

Co-authorship network of co-authors of Preeti Shah

This figure shows the co-authorship network connecting the top 25 collaborators of Preeti Shah. A scholar is included among the top collaborators of Preeti Shah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Preeti Shah. Preeti Shah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shah, Preeti, et al.. (2023). Investigating the potential role of swertiamarin on insulin resistant and non-insulin resistant granulosa cells of poly cystic ovarian syndrome patients. Journal of Ovarian Research. 16(1). 55–55. 4 indexed citations

Knudsen, Steen, Marie L. Foegh, Steen V. Petersen, et al.. (2023). A novel drug specific mRNA biomarker predictor for selection of patients responding to dovitinib treatment of advanced renal cell carcinoma and other solid tumors. PLoS ONE. 18(8). e0290681–e0290681. 1 indexed citations

Shah, Preeti, et al.. (2020). EFFECT OF DUAL TASK EXERCISES ON REACTION TIME IN SCHOOL BASKETBALL PLAYERS. International Journal of Physiotherapy and Research. 8(6). 3688–3692. 2 indexed citations

Shah, Preeti. (2019). A Review of Salt Therapy as a Complementary Treatment for Enhancing Respiratory Wellness and Skin Ailment. 72(5). 28–32. 3 indexed citations

Trucco, Matteo, Christian F. Meyer, Katherine A. Thornton, et al.. (2018). A phase II study of temsirolimus and liposomal doxorubicin for patients with recurrent and refractory bone and soft tissue sarcomas. SHILAP Revista de lepidopterología. 8(1). 21–21. 22 indexed citations

Shah, Preeti, et al.. (2016). Dual effect of insulin resistance and cadmium on human granulosa cells - In vitro study. Toxicology and Applied Pharmacology. 313. 119–130. 19 indexed citations

Kazi, Armina A., et al.. (2015). Histone Deacetylase Inhibitor Entinostat Inhibits Tumor-Initiating Cells in Triple-Negative Breast Cancer Cells. Molecular Cancer Therapeutics. 14(8). 1848–1857. 79 indexed citations

Shah, Preeti, Gauri Sabnis, Olga Goloubeva, et al.. (2015). Histone deacetylase inhibitor entinostat in combination with a retinoid downregulates HER2 and reduces the tumor initiating cell population in aromatase inhibitor-resistant breast cancer. Breast Cancer Research and Treatment. 152(3). 499–508. 10 indexed citations

Meyer, Christian F., Katherine A. Thornton, Matteo Trucco, et al.. (2015). A phase II study of temsirolimus and liposomal doxorubicin for patients with recurrent and refractory bone and soft tissue sarcomas.. Journal of Clinical Oncology. 33(15_suppl). 10560–10560. 2 indexed citations

10.

Kazi, Armina A., Rabia A. Gilani, Saranya Chumsri, et al.. (2014). Nonhypoxic regulation and role of hypoxia-inducible factor 1 in aromatase inhibitor resistant breast cancer. Breast Cancer Research. 16(1). R15–R15. 33 indexed citations

11.

Sabnis, Gauri, Olga Goloubeva, Armina A. Kazi, Preeti Shah, & Angela Brodie. (2013). HDAC Inhibitor Entinostat Restores Responsiveness of Letrozole-Resistant MCF-7Ca Xenografts to Aromatase Inhibitors through Modulation of Her-2. Molecular Cancer Therapeutics. 12(12). 2804–2816. 53 indexed citations

12.

Chumsri, Saranya & Preeti Shah. (2013). Radiation resistance of cancer stem cells as an obstacle in cancer therapy. 5(1). 39–49. 4 indexed citations

13.

Sabnis, Gauri, et al.. (2013). Effect of selumetinib on the growth of anastrozole-resistant tumors. Breast Cancer Research and Treatment. 138(3). 699–708. 11 indexed citations

14.

Shah, Preeti, et al.. (2013). Histone deacetylase inhibitor entinostat reverses epithelial to mesenchymal transition of breast cancer cells by reversing the repression of E-cadherin. Breast Cancer Research and Treatment. 143(1). 99–111. 71 indexed citations

15.

Trucco, Matteo, Ola Awad, Breelyn A. Wilky, et al.. (2013). A Novel Chordoma Xenograft Allows In Vivo Drug Testing and Reveals the Importance of NF-κB Signaling in Chordoma Biology. PLoS ONE. 8(11). e79950–e79950. 19 indexed citations

16.

Gilani, Rabia A., Armina A. Kazi, Preeti Shah, et al.. (2012). The importance of HER2 signaling in the tumor-initiating cell population in aromatase inhibitor-resistant breast cancer. Breast Cancer Research and Treatment. 135(3). 681–692. 31 indexed citations

17.

Laheru, Daniel A., Preeti Shah, N.V. Rajeshkumar, et al.. (2012). Integrated preclinical and clinical development of S-trans, trans-farnesylthiosalicylic acid (FTS, Salirasib) in pancreatic cancer. Investigational New Drugs. 30(6). 2391–2399. 85 indexed citations

18.

Awad, Ola, Jason T. Yustein, Preeti Shah, et al.. (2010). High ALDH Activity Identifies Chemotherapy-Resistant Ewing's Sarcoma Stem Cells That Retain Sensitivity to EWS-FLI1 Inhibition. PLoS ONE. 5(11). e13943–e13943. 121 indexed citations

19.

Shah, Preeti, Antonio Jimeno, Belén Rubio‐Viqueira, et al.. (2007). In vivo testing of Mycophenolic acid (MPA) in primary pancreatic cancer (PaCa) xenografts. Cancer Research. 67. 2213–2213. 1 indexed citations

20.

Datta, Kamal, et al.. (2003). Hydroxylamine potentiates the effect of low dose hydrogen peroxide in glioma cells independent of p53. The International Journal of Biochemistry & Cell Biology. 35(12). 1639–1644. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact